• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于吡唑啉的 MAO 抑制剂:合成、生物评价和 SAR 研究。

Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.

机构信息

Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India.

出版信息

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4296-300. doi: 10.1016/j.bmcl.2011.05.057. Epub 2011 May 25.

DOI:10.1016/j.bmcl.2011.05.057
PMID:21680183
Abstract

Twenty-two pyrazoline derivatives were synthesized and tested for their human MAO (hMAO) inhibitory activity. Twelve molecules with unsubstituted ring A and substituted ring C (5-16) were found to be potent inhibitors of hMAO-A isoform with SI(MAO-A) in the order 10(3) and 10(4). Ten molecules with unsubstituted ring A and without ring C (21-30), in which eight molecules (21, 23-26, and 28-30) were selective for hMAO-A, one for hMAO-B (22) and the other one non-selective (27). Presence of ring C increases potency as well as SI towards hMAO-A; however its absence decreases both potency and SI towards hMAO-A and hMAO-B.

摘要

合成了 22 种吡唑啉衍生物,并测试了它们对人单胺氧化酶(hMAO)的抑制活性。12 种 A 环未取代且 C 环取代的分子(5-16)对 hMAO-A 同工酶表现出很强的抑制活性,SI(MAO-A)值在 10(3)到 10(4)之间。10 种 A 环未取代且无 C 环的分子(21-30)中,有 8 种分子(21、23-26 和 28-30)对 hMAO-A 具有选择性,1 种对 hMAO-B(22)具有选择性,另 1 种是非选择性的(27)。C 环的存在增加了对 hMAO-A 的活性和选择性指数;然而,它的缺失降低了对 hMAO-A 和 hMAO-B 的活性和选择性指数。

相似文献

1
Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.基于吡唑啉的 MAO 抑制剂:合成、生物评价和 SAR 研究。
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4296-300. doi: 10.1016/j.bmcl.2011.05.057. Epub 2011 May 25.
2
Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.朝向基于吡唑啉的 MAO 抑制剂的选择性和可逆性发展:合成、生物评估和对接研究。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):132-6. doi: 10.1016/j.bmcl.2009.11.015. Epub 2009 Nov 12.
3
Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.一些新型腙和2-吡唑啉衍生物的合成:单胺氧化酶抑制活性及对接研究
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3278-84. doi: 10.1016/j.bmcl.2014.06.015. Epub 2014 Jun 17.
4
Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.基于吡唑啉的选择性和可逆单胺氧化酶-A 抑制剂的开发:合成、生物评价和对接研究。
Bioorg Med Chem. 2010 Mar 1;18(5):1875-81. doi: 10.1016/j.bmc.2010.01.043. Epub 2010 Jan 25.
5
Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.色满酮-2-和-3-羧酸抑制单胺氧化酶 A 和 B 的方式不同。
Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12. doi: 10.1016/j.bmcl.2010.03.081. Epub 2010 Mar 27.
6
Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.3,5-二芳基-4,5-二氢-1H-吡唑-1-羧酸酯衍生物的单胺氧化酶抑制活性。
Eur J Med Chem. 2013 Nov;69:762-7. doi: 10.1016/j.ejmech.2013.09.010. Epub 2013 Sep 18.
7
Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.新型2-吡唑啉-1-乙酮衍生物作为选择性单胺氧化酶抑制剂的设计与合成
Bioorg Med Chem. 2015 Feb 1;23(3):515-25. doi: 10.1016/j.bmc.2014.12.010. Epub 2014 Dec 13.
8
Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.作为 MAO-B 抑制剂的烯丙基吡唑啉的合成和分子建模研究。
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6479-82. doi: 10.1016/j.bmcl.2010.09.061. Epub 2010 Sep 17.
9
Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.1-乙酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑衍生物对单胺氧化酶的合成及选择性抑制活性
J Med Chem. 2004 Apr 8;47(8):2071-4. doi: 10.1021/jm031042b.
10
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.色酮 3-苯甲酰胺类作为强效和选择性 MAO-B 抑制剂。
Bioorg Med Chem Lett. 2011 Jan 15;21(2):707-9. doi: 10.1016/j.bmcl.2010.11.128. Epub 2010 Dec 5.

引用本文的文献

1
Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives.不同取代吡唑衍生物的多样化药理学潜力。
Curr Org Synth. 2024;21(7):858-888. doi: 10.2174/0115701794260444230925095804.
2
Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders.含吡唑啉化合物作为神经退行性疾病的治疗靶点
ACS Omega. 2022 Oct 17;7(43):38207-38245. doi: 10.1021/acsomega.2c05339. eCollection 2022 Nov 1.
3
Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor ()-ND-336.选择性基质金属蛋白酶-9抑制剂()-ND-336的代谢
ACS Pharmacol Transl Sci. 2021 Apr 6;4(3):1204-1213. doi: 10.1021/acsptsci.1c00063. eCollection 2021 Jun 11.
4
Design, Synthesis, Docking Studies and Monoamine Oxidase Inhibition of a Small Library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles.设计、合成、对接研究及单胺氧化酶抑制的 1-乙酰基-和 1-硫代甲酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑小分子库。
Molecules. 2019 Jan 29;24(3):484. doi: 10.3390/molecules24030484.
5
Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A.基于姜黄素的吡唑啉类似物作为人单胺氧化酶A的选择性抑制剂。
Medchemcomm. 2018 Jun 8;9(7):1164-1171. doi: 10.1039/c8md00196k. eCollection 2018 Jul 1.
6
N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies.用于神经系统疾病的N1-苯磺酰基-2-吡唑啉杂化物:合成、生物学筛选及计算研究
EXCLI J. 2018 Jan 19;17:126-148. doi: 10.17179/excli2017-871. eCollection 2018.
7
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.新型吡唑啉类似物的单胺氧化酶抑制活性:基于姜黄素的设计与合成
ACS Med Chem Lett. 2015 Dec 1;7(1):56-61. doi: 10.1021/acsmedchemlett.5b00326. eCollection 2016 Jan 14.